Uro-Podcasters Love-in!! GU Cast hook up with Uromigos and OncoAlert on the shores of Lake Lugano Advanced Prostate Cancer Consensus Conference #APCCC24 . Such a fun podcast! Thanks Brian Rini, MD Tom Powles Gil Morgan, MD for joining Renu Eapen Declan Murphy youtu.be/DjzbsBmMQOA?si…

#APCCC24 Advanced Prostate Cancer Consensus Conference 👉 majority of panelist favor offering Lutetium-177 RLT Rx after ARPI and docetaxel Rx in mCRPC #prostatecancer 👇 OncoAlert PCF Science

#APCCC24 Advanced Prostate Cancer Consensus Conference 👉Excellent talk by Heather H. Cheng on who should undergo germ line testing?👉ongoing neoadjuvant trials in germline mutation+ #prostatecancer and take home message👇OncoAlert PCF Science silke gillessen

#APCCC2024 Advanced Prostate Cancer Consensus Conference 👉 Excellent talk by Elena Castro on management of adverse events of PARP inhibitors 👉Grade 3-4 toxicity occurs early in 3-4 months, and timely dose reduction allows pts to continue Rx👉The benefit outweighs side effects👇 OncoAlert silke gillessen

#APCCC2024 Advanced Prostate Cancer Consensus Conference 👉 Majority of panelists favor using PARPi ( mono or combinations) in metastatic #prostatecancer beyond BRCA2 mutations👉in BRCA1, ATM, RAD51C, PALB2, & CDK12 mutations OncoAlert silke gillessen Oncology Brothers

#APCCC2024 Advanced Prostate Cancer Consensus Conference 👉 Excellent points raised by Ian Davis on sequencing of Rx in metastatic #prostatecancer 👉key principles & his suggestions for sequencing of Rx👇OncoAlert PCF Science silke gillessen

#APCCC24
Cardiologist Dr. Thomas Suter highlighting CV toxicity of systemic therapies for metastatic prostate cancer

💥ADT, by far, the worst culprit
UroToday.com

Excellent tips on how to treat frail patients with #prostatecancer from M De Santis
⭕️Aging doesn’t mean frailty itself! It’s imperative to make right diagnosis!
⭕️Do not offer ADT alone as a default to elderly and individualize the treatment
⭕️Pay attention to patient goal and…

What are the recommended imaging modalities in mCSPC? Michael Morris
⭕️ Unclear what is the best imaging algorithm !
#Apccc24 Advanced Prostate Cancer Consensus Conference silke gillessen aurelius omlin OncoAlert Thomas Zilli Daniel Castellano Piet Ost Emre Yekedüz Dra. María Natalia Gandur Quiroga Irbaz Riaz MD,MS,MBI,PhD Deborah Mukherji Neeraj Agarwal, MD, FASCO…

Thomas Zilli on the use of “total therapy” at #APCCC24
Patient risk stratification is key.
Multiple options to chose from!

Interesting voting results from #apccc24 consensus panel on whether ePLND should still be done with negative PSMA PET for unfavorable intermediate, high and very high risk #ProstateCancer

Excellent lecture by Paul Nguyen on whole pelvis radiation for N1 #prostatecancer recurrence #apccc24

🩺 On European Urology - Oligometastatic Bladder Cancer: Defining a Novel Entity

#BladderCancer Chris Labaki Toni Choueiri, MD Eddy Saad joaquim bellmunt

europeanurology.com/article/S0302-…

👉Video preview of the most exciting trials on #prostatecancer being presented @ #AUA24

🙏Urology Times

✨PSMAfore - LuPSMA prior to chemotherapy for mCRPC

✨Apa-RP - Adjuvant apalutamide & ADT for high-risk PCa

✨DAROL (PD01-03)- Darolutamide for nmCRPC

✨Update on EMBARK…

#APCCC2024 Advanced Prostate Cancer Consensus Conference 👉 outstanding talk by Nick James on triplet vs doublet therapy in mCSPC #ProstateCancer 👉gives shoutout to network meta-analysis by SOUMYAJIT ROY 👉value of triplet unclear in all pts, pts QOL should be considered OncoAlert silke gillessen

#APCCC2024 Advanced Prostate Cancer Consensus Conference 👉 #OliverSartor 👉is there any role of total therapy 👇 in synchronous low volume mCSPC #ProstateCancer 👉no data showing value of MDT or superiority of triplet over ADT+ ARPI👇Summary👉pts’s wishes should drive aggressive Rx OncoAlert silke gillessen

#APCCC2024 Advanced Prostate Cancer Consensus Conference 👉 Michael Morris Mike Morris👉Regular conventional imaging is must in pts with mCSPC #ProstateCancer 👉Arches trial data showed imaging progression (minus PSA rise) in many, and lineage plasticity makes PSA/PSMA unreliable. OncoAlert silke gillessen

#APCCC2024 Advanced Prostate Cancer Consensus Conference 👉 Rx of nodal recurrence after surgery for #ProstateCancer and without prior salvage RT 👉Panel favors whole pelvis + prostate radiation over SBRT to the nodes OncoAlert UroToday.com silke gillessen aurelius omlin

How do we approach high-risk prostate cancer with a biochemical recurrence after surgery? The choice between local and systemic therapy hinges on the location of the recurrence, guided by risk stratification and PSA kinetics. tombal
#Apccc24 Advanced Prostate Cancer Consensus Conference…

Check out the Cheat Sheet on the treatment of #ErectileDysfunction . The management algorithm outlines modifiable factors and current therapies for successful treatment. While ED can't always be cured, effective management is possible.

#EAUguidelines

uroweb.org/guidelines/sex…